Vir Biotechnology to Participate in the 42nd Annual Cowen Healthcare Conference

Rhea-AI Summary

Vir Biotechnology will participate in a panel discussion on infectious diseases at the 42nd Annual Cowen Healthcare Conference on March 9, 2022, at 10:30 a.m. ET. The event will be held virtually, and a live webcast can be accessed through the Investors section of the Vir website, where it will also be archived for 30 days.

Vir Biotechnology focuses on developing treatments for serious infectious diseases using innovative immunologic technologies. Its pipeline includes candidates for COVID-19, hepatitis B, influenza A, and HIV.

SAN FRANCISCO, March 02, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in an infectious disease panel discussion at the 42^nd Annual Cowen Healthcare Conference on Wednesday, March 9, at 10:30 a.m. ET.

The conference will be held virtually. A live webcast of the panel discussion can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.

About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B virus, influenza A and human immunodeficiency virus. Vir routinely posts information that may be important to investors on its website.

FAQ

When is Vir Biotechnology participating in the Cowen Healthcare Conference?

Vir Biotechnology will participate in the Cowen Healthcare Conference on March 9, 2022, at 10:30 a.m. ET.

How can I watch the Vir Biotechnology panel discussion?

The panel discussion can be watched live on the Investors section of Vir Biotechnology's website.

What topics will Vir Biotechnology discuss at the conference?

Vir Biotechnology will discuss infectious diseases at the panel during the conference.

What is the focus of Vir Biotechnology's development pipeline?

Vir Biotechnology's pipeline focuses on treatments for COVID-19, hepatitis B, influenza A, and HIV.

Where can I find the archived webcast of Vir Biotechnology's conference discussion?

The archived webcast will be available on the Investors section of Vir Biotechnology's website for 30 days.